EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CpG ODN Activates TLR9 and Upregulates TLR3 via the p38 MAPK-ATF3 Signaling Axis to Synergistically Enhance Dendritic Cell Vaccine Efficacy

Lv Zhou, Zhuowei Lei, Qian Jiang, Linpeng Xu, Quanji Wang, Yimin Huang, Ting Lei iD

Cells · 2025

DOI: 10.3390/cells14221785 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Lv Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science …. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Dendritic Cells, Toll-Like Receptor 9, Oligodeoxyribonucleotides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Celarts Biosciences Group Co., Ltd, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Toll-like receptor 9 (TLR9) and Toll-like receptor 3 (TLR3), which are widely expressed in dendritic cells (DCs), function as key pattern recognition receptors (PRRs) in the immune system. Their primary roles involve specifically detecting pathogen-associated molecular patterns (PAMPs): TLR9 recognizes unmethylated CpG motifs predominantly found in bacterial and viral DNA, while TLR3 identifies viral double-stranded RNA (dsRNA), a molecular signature associated with viral replication. Their specific agonists [CpG ODN (a TLR9 agonist) and poly(I:C) (a TLR3 agonist)] can effectively activate DCs and enhance the expression of immune activation-related molecules. In this study, by establishing a mouse primary dendritic cell model and a glioma-bearing mouse model, and employing techniques such as transcriptome sequencing, we found that combined stimulation with CpG ODN and poly(I:C) significantly enhanced the anti-tumor function of DCs: in vitro, DCs subjected to combined stimulation showed upregulation of anti-tumor-related surface markers, enhanced migratory capacity, and a more effective activation of CD8+ T cells; in vivo, a DC vaccine loaded with tumor lysate antigen and stimulated with this combined regimen significantly delayed the progression of glioma in tumor-bearing mice. Further investigation revealed that the underlying mechanism for this enhanced effect may involve TLR9 activation promoting TLR3 upregulation through the p38 MAPK-ATF3 signaling axis. Consequently, we designed a sequential stimulation protocol (first CpG ODN then poly(I:C)), which demonstrated a stronger anti-glioma effect compared to simple combined stimulation. This study provides a new strategy for enhancing the immune efficacy of DC vaccines and has potential significance for promoting the clinical translation of DC vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 3Dendritic CellsToll-Like Receptor 9Oligodeoxyribonucleotidesp38 Mitogen-Activated Protein KinasesActivating Transcription Factor 3Cancer VaccinesAnimalsMiceMice, Inbred C57BLSignal TransductionPoly I-CUp-RegulationGliomaCell Line, Tumor

Stichwörter der Autor:innen

dendritic cell vaccinegliomaimmunotherapytoll-like receptor

Substanzen

Toll-Like Receptor 3Toll-Like Receptor 9Oligodeoxyribonucleotidesp38 Mitogen-Activated Protein KinasesCPG-oligonucleotideTLR3 protein, mouseActivating Transcription Factor 3Cancer VaccinesPoly I-CAtf3 protein, mouse

Autor:innen und Institutionen

  • Sino-German Neuro-Oncology Molecular Laboratory, Department of Neurosurgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.
  • Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan 430030, China.
  • Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.

ORCID-Profile: Ting Lei

Förderung

  • Beijing Celarts Biosciences Group Co., Ltd
  • National Natural Science Foundation of China

Zitieren

APA

Zhou, L., Lei, Z., Jiang, Q., Xu, L., Wang, Q., Huang, Y., & Lei, T. (2025). CpG ODN Activates TLR9 and Upregulates TLR3 via the p38 MAPK-ATF3 Signaling Axis to Synergistically Enhance Dendritic Cell Vaccine Efficacy. Cells. https://doi.org/10.3390/cells14221785

Vancouver

Zhou L, Lei Z, Jiang Q, Xu L, Wang Q, Huang Y, et al. CpG ODN Activates TLR9 and Upregulates TLR3 via the p38 MAPK-ATF3 Signaling Axis to Synergistically Enhance Dendritic Cell Vaccine Efficacy. Cells. 2025. doi:10.3390/cells14221785

BibTeX
@article{Zhou2025,
  author = {Zhou, Lv and Lei, Zhuowei and Jiang, Qian and Xu, Linpeng and Wang, Quanji and Huang, Yimin and Lei, Ting},
  title = {CpG ODN Activates TLR9 and Upregulates TLR3 via the p38 MAPK-ATF3 Signaling Axis to Synergistically Enhance Dendritic Cell Vaccine Efficacy},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14221785}
}
Kostenlos starten →